Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alexander's

206.40
+0.90000.44%
Post-market: 206.400.00000.00%19:26 EDT
Volume:10.75K
Turnover:2.21M
Market Cap:1.05B
PE:24.40
High:208.17
Open:203.55
Low:203.50
Close:205.50
Loading ...

UBS Cuts Price Target on ALX Oncology Holdings to $2.20 From $4, Keeps Buy Rating

MT Newswires Live
·
27 Jan

Alexander’s, Inc. (ALX): Why You Should Invest In This Extreme Dividend Stock Now

Insider Monkey
·
26 Jan

ALX Oncology Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
24 Jan

Promising Phase 2 ASPEN-06 Study Positions ALX Oncology’s Evorpacept as a Strong Contender in HER2+ Gastric Cancer Treatment

TIPRANKS
·
24 Jan

ALX Oncology price target lowered to $5 from $25 at H.C. Wainwright

TIPRANKS
·
24 Jan

ALX Oncology Shares Drop 15% Following Positive Phase 2

GuruFocus.com
·
24 Jan

ALX Oncology Presents Positive Updated Data from ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Generates Strong Response and Durable Clinical Benefit in Patients with HER2-Positive Gastric Cancer

GlobeNewswire
·
23 Jan

ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules

GlobeNewswire
·
23 Jan

ALX Oncology Names New CFO; Shares Rise

MT Newswires Live
·
23 Jan

ALX Oncology Strengthens Leadership with Key Appointments

TIPRANKS
·
22 Jan

Press Release: ALX Oncology Announces Further Additions to Leadership Team and Board of Directors, Appointing Harish Shantharam as Chief Financial Officer and Adding Barbara Klencke and Chris Takimoto to Board of Directors

Dow Jones
·
22 Jan

ALX Oncology to Host Virtual Company Event Highlighting Updated Data from ASPEN-06 Phase 2 Trial Presented at 2025 ASCO GI

GlobeNewswire
·
22 Jan

ALX Oncology Adopts 2025 Inducement Equity Plan

TIPRANKS
·
18 Jan

ALX Oncology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire
·
07 Jan

Greenridge Exploration Expands with ALX Acquisition

TIPRANKS
·
31 Dec 2024

TPG in Advanced Talks to Acquire Crown Castle's Fiber Unit

Zacks
·
21 Dec 2024

ALX Oncology Shares Fall After Downgrade From Jefferies

MT Newswires Live
·
20 Dec 2024

Here's Why You Should Retain Ventas Stock in Your Portfolio Now

Zacks
·
20 Dec 2024

Jefferies Downgrades ALX Oncology to Hold From Buy, Cuts Price Target to $2 From $12

MT Newswires Live
·
19 Dec 2024

ALX Oncology to Present Updated Results from Phase 2 ASPEN-06 Clinical Trial of Evorpacept in Patients with HER2-Positive Gastric Cancer in Oral Presentation at 2025 ASCO Gastrointestinal Cancers Symposium

GlobeNewswire
·
18 Dec 2024